Characteristics N (%)
Age group (years)  
<1 11(12.5)
1-5 20(22.7)
6-12 53(60.2)
>12 4(4.6)
Mean age in months (SD) 72.23 ± 41.06
Gender  
Male 47(53.4)
Female 41(46.6)
WHO Stage  
1 49(55.7)
2 14(15.9)
3 19(21.6)
4 6(6.8)
CD4Count  
Median (IQR) 104 (53-157)
<50 20(22.7)
51-100 24(27.3)
101-198 44(50.0)
Viral Load  
Median (IQR) 3016(200-39,354)
≤1000 31(35.2)
1001-10,000 24(27.3)
10,001-100,000 22(25.0)
>100,000 11(12.5)
Detectable 63(71.6)
Undetectable 25(28.4)
On HAART  
Yes 77(87.5)
No 11(12.5)
Types of HAART  
AZT/3TC/LPVr 5(5.7)
AZT/3TC/NVP 44(50.0)
D4T/3TC/NVP 8(9.1)
AZT/3TC/EFV 12(13.6)
ABC/3TC/EFV 2(2.3)
ABC/3TC/LPVr 17(19.3)
Age range is 12-168 months, CD4 count range is from 10 to 198 cells/mm3, SD=Standard deviation, IQR=Interquartile range.
Table 1: Some demographic, clinical and Immunoviralogical characteristics of the subjects.